Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 3
1988 1
1989 2
1990 4
1991 4
1992 5
1993 4
1994 3
1995 4
1996 4
1997 8
1998 5
1999 1
2000 6
2001 2
2002 8
2003 2
2004 10
2005 6
2006 11
2007 23
2008 37
2009 43
2010 45
2011 27
2012 21
2013 28
2014 18
2015 18
2016 32
2017 26
2018 19
2019 17
2020 35
2021 43
2022 30
2023 24
2024 15

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

523 results

Results by year

Filters applied: . Clear all
Page 1
Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease.
Salloway S, Sperling R, Fox NC, Blennow K, Klunk W, Raskind M, Sabbagh M, Honig LS, Porsteinsson AP, Ferris S, Reichert M, Ketter N, Nejadnik B, Guenzler V, Miloslavsky M, Wang D, Lu Y, Lull J, Tudor IC, Liu E, Grundman M, Yuen E, Black R, Brashear HR; Bapineuzumab 301 and 302 Clinical Trial Investigators. Salloway S, et al. N Engl J Med. 2014 Jan 23;370(4):322-33. doi: 10.1056/NEJMoa1304839. N Engl J Med. 2014. PMID: 24450891 Free PMC article. Clinical Trial.
Cost-effectiveness of Evolocumab.
Escobar C, Barrios V. Escobar C, et al. Among authors: barrios v. Rev Esp Cardiol (Engl Ed). 2018 Dec;71(12):1089. doi: 10.1016/j.rec.2018.04.028. Epub 2018 Jul 7. Rev Esp Cardiol (Engl Ed). 2018. PMID: 30509368 English, Spanish. No abstract available.
SGLT 2 inhibitors: Searching for the best in class.
Escobar C, Barrios V. Escobar C, et al. Among authors: barrios v. Int J Cardiol. 2023 Aug 1;384:48-49. doi: 10.1016/j.ijcard.2023.04.025. Epub 2023 Apr 20. Int J Cardiol. 2023. PMID: 37085120 No abstract available.
Rivaroxaban: searching the integral vascular protection.
Barrios V, Almendro-Delia M, Facila L, Garcia-Moll X, Mazón P, Camafort M, Cepeda JM, Mediavilla Garcia JD, Pose Reino A, Suarez Fernandez C. Barrios V, et al. Expert Rev Clin Pharmacol. 2018 Jul;11(7):719-728. doi: 10.1080/17512433.2018.1495559. Epub 2018 Jul 18. Expert Rev Clin Pharmacol. 2018. PMID: 29965791 Review.
Peptides and food intake.
Sobrino Crespo C, Perianes Cachero A, Puebla Jiménez L, Barrios V, Arilla Ferreiro E. Sobrino Crespo C, et al. Among authors: barrios v. Front Endocrinol (Lausanne). 2014 Apr 24;5:58. doi: 10.3389/fendo.2014.00058. eCollection 2014. Front Endocrinol (Lausanne). 2014. PMID: 24795698 Free PMC article. Review.
[Chronic kidney disease and dyslipidaemia].
Pascual V, Serrano A, Pedro-Botet J, Ascaso J, Barrios V, Millán J, Pintó X, Cases A. Pascual V, et al. Among authors: barrios v. Clin Investig Arterioscler. 2017 Jan-Feb;29(1):22-35. doi: 10.1016/j.arteri.2016.07.004. Epub 2016 Nov 15. Clin Investig Arterioscler. 2017. PMID: 27863896 Review. Spanish.
Pregnancy-Associated Plasma Protein (PAPP)-A2 in Physiology and Disease.
Barrios V, Chowen JA, Martín-Rivada Á, Guerra-Cantera S, Pozo J, Yakar S, Rosenfeld RG, Pérez-Jurado LA, Suárez J, Argente J. Barrios V, et al. Cells. 2021 Dec 18;10(12):3576. doi: 10.3390/cells10123576. Cells. 2021. PMID: 34944082 Free PMC article. Review.
Somatostatin and Alzheimer's disease.
Burgos-Ramos E, Hervás-Aguilar A, Aguado-Llera D, Puebla-Jiménez L, Hernández-Pinto AM, Barrios V, Arilla-Ferreiro E. Burgos-Ramos E, et al. Among authors: barrios v. Mol Cell Endocrinol. 2008 May 14;286(1-2):104-11. doi: 10.1016/j.mce.2008.01.014. Epub 2008 Feb 3. Mol Cell Endocrinol. 2008. PMID: 18359553 Review.
523 results